Patents by Inventor Lori Steiner

Lori Steiner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11124840
    Abstract: Provided herein are methods and compositions to classify DLBCL subtypes using quantitative RT-PCR.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: September 21, 2021
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Rajiv Dua, Marcel Fontecha, Yan Li, Wei-min Liu, Christopher Santini, Lori Steiner, Yu Chuan Tai
  • Publication number: 20190177770
    Abstract: Provided herein are methods and compositions for isolating and detecting nucleic acids from platelet-enriched plasma.
    Type: Application
    Filed: December 7, 2018
    Publication date: June 13, 2019
    Inventors: Emma Brown, Dwight Kuo, Chitra Manohar, Priscilla Moonsamy, Sneha Nishtala, Lori Steiner
  • Publication number: 20190144947
    Abstract: Provided herein are methods and compositions to classify DLBCL subtypes using quantitative RT-PCR.
    Type: Application
    Filed: May 11, 2017
    Publication date: May 16, 2019
    Inventors: Rajiv Dua, Marcel Fontecha, Yan Li, Wei-min Liu, Christopher Santini, Lori Steiner, Yu Chuan Tai
  • Patent number: 9963748
    Abstract: Provided herein are methods and compositions to classify DLBCL subtypes using quantitative RT-PCR.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: May 8, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Rajiv Dua, Marcel Fontecha, Yan Li, Wei-min Liu, Christopher Santini, Lori Steiner, Yu Chuan Tai
  • Publication number: 20170327897
    Abstract: Provided herein are methods and compositions to classify DLBCL subtypes using quantitative RT-PCR.
    Type: Application
    Filed: May 11, 2017
    Publication date: November 16, 2017
    Inventors: Rajiv Dua, Marcel Fontecha, Yan Li, Wei-min Liu, Christopher Santini, Lori Steiner, Yu Chuan Tai
  • Patent number: 8614071
    Abstract: The present invention relates to a method, oligonucleotides, reaction mixtures and kits for the selective amplification of a messenger RNA target comprising an exon-exon junction, using an oligonucleotide that comprises at least one nucleotide modified at the exocyclic amino group.
    Type: Grant
    Filed: December 8, 2010
    Date of Patent: December 24, 2013
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Stephen Will, Lori Steiner, Alison Tsan, Nicolas Newton
  • Publication number: 20110312040
    Abstract: The present invention relates to a method, oligonucleotides, reaction mixtures and kits for the selective amplification of a messenger RNA target comprising an exon-exon junction, using an oligonucleotide that comprises at least one nucleotide modified at the exocyclic amino group.
    Type: Application
    Filed: December 8, 2010
    Publication date: December 22, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Stephen Will, Lori Steiner, Alison Tsan, Nicolas Newton